Luceco Share Discussion Threads

[jolomo] 20/2/2022 20:15

Thanks Jam, I think you may have nailed it. PDMR's refer to Jonathan but in presentations refers to himself as John & as does company website.

[jamtin] 20/2/2022 19:59

Isn't the CEOs name John Hornby not Jonathan Hornby? Search John Hornby Luceco and you do get quite a number of news articles. You still get the disclaimer about "some results may have been removed" but I see that almost every search I make anyway.

[ymaheru] 18/2/2022 16:32

Price is lovely around 260p.

Trading update was ok on January, also.
Adj Operating Profit leapt 30% to £39m, with similar margins.
Due to tax benefits last year, I expect this year to be just over 21p EPS.

2022 going well, also. They’re passing on costs slowly. Reading into that, I’d hope for 20% EPS growth again.

They also talk of “reinvigorated M&A activity”, so I’d think we might see EPS of 25%+ in 2022.

The business is still growing at a rate, and looking acquisitive again.

I don’t know if the share price will fall further, but I’ve put in a limit order just in case.

[dr biotech] 18/2/2022 16:12

I got out at a loss at 290. It’s going to be a tough few months, will keep an eye on it

[jolomo] 18/2/2022 15:27

Considering buying back in but the recent director sale making me extra cautious at the moment. Perhaps nothing in the removal of news re CEO, but I remain a little too wary for now.

[dr biotech] 18/2/2022 15:04

Perhaps there aren’t any? Can’t find anything with others or using Tor

[jolomo] 18/2/2022 14:26

Appreciate the response and agree does often come up but what's odd is that all news articles bar one have been removed. Why?

[dr biotech] 18/2/2022 14:06

Comes up almost all the time when you search names, just you probably never notice. Try searching any reasonably common name, “david james” and that disclaimer pops up.

[jolomo] 18/2/2022 13:43

Anyone have an idea why if I search 'Jonathan Hornby luceco' on google news it appears that the results have been wiped, stating that 'Some results may have been removed under data protection law in Europe'.

[ymaheru] 20/1/2022 15:52

Thanks Dr Bio.
I see it there. Just wasn’t on their own website yet!

Everything was just in line with previous guidance. That’s still excellent as far as I can see.

Sounds like they are confident of new acquisitions in FY22.

Yes, I saw that late trade yesterday.

[dr biotech] 20/1/2022 14:45

Its showing as normal - seems decent enough



SP is actually up today, if you look at the trade quotes. There was an outlier trade last night that gave an anomolous high price.

[ymaheru] 20/1/2022 14:14

Does anyone know what happened to the full year trading update today?

It’s on the financial calendar:
hxxps://www.lucecoplc.com/reports-and-information/financial-calendar/

[johnrxx99] 01/12/2021 07:01

Good reversal yesterday

[dicktrade] 04/11/2021 10:29

i noticed a 78000 share buy go thru this morning.

Richard

[bigbigdave] 04/11/2021 10:08

Tipped in shares mag today

[mfhmfh] 21/10/2021 17:42

Liberum - 520p target.

Numis - 480p target.

[dr biotech] 21/10/2021 11:05

Seems decent enough to me given the circumstances. Some compression of margins to be expected- long term they seem to be on top of everything.

[ymaheru] 21/10/2021 08:10

1- positive news that they have not altered 2021 forecasts.

2- still saying ‘adjusted̵7; profit up minimum 30%, slightly lower than what I’d hoped but still very very good

3- they did say high shipping and commodity costs and Chinese energy issues will affect them for next 6-9 months, but still expect good year and further growth in 2022.

4- made one acquisition, which will improve profits around 5% by next year, and looking at other acquisitions. That’s all good.

*Conclusions*
- done well in tough environment
- still a good long term hold
- I don’t know if market will react well or not today- hoping it’ll reverse some of the drops since Sept 7th
- I won’t be selling any shares

[slogsweep] 21/10/2021 07:59

positive update?

[dr biotech] 20/10/2021 15:27

Not the most confident share price action going into the update. Some disruption but manageable is probably the best we can hope for. Given the near 40% drop (admittedly from perhaps an over inflated peak) I’d hope that’s already priced in and anything better will take us up.

[ihatemms] 20/10/2021 11:24

It’s tomorrow.

[capitalist] 20/10/2021 11:01

Looks like the Q3 trading udate should be out soon, given that there was one on the 20th October 2020.

[tole] 13/10/2021 20:20

https://www.fool.co.uk/investing/2021/10/13/these-growth-shares-have-tumbled-over-40-time-to-buy/These growth shares have tumbled over 40%! Time to buy?LucecoIf Victorian Plumbing's valuation still appears a little too rich, lighting specialist Luceco (LSE: LUCE) is looking far more palatable. Right now, the near-£500m cap company's stock changes hands for a little over 15 times earnings. Sadly, my bullish call on LUCE just over one month ago wasn't shared by the market. Despite reporting very decent numbers and raising the interim dividend by 73%, investors have elected to abandon the stock en masse. All told, LUCE shares were down 41% before markets opened today since hitting an all-time high in early September. Then again, they're still up 41% in the last 12 months. In my defence, I questioned whether the lack of buying activity on the day did suggest investors were concerned by the firm's comments relating to significant cost inflation and supply chain setbacks. Even so, I underestimated just how great this concern was. Some director selling hasn't helped matters.Of course, short-term setbacks may be regarded as opportunities for long-term investors such as myself. This remains a quality business, in my opinion. Bar the odd blip, margins and returns on capital have been consistently great. The aforementioned cash returns should also be sufficient compensation while investors await a recovery. How long that recovery takes is debatable, of course. Far from switching off from this growth stock, I'd be comfortable starting to build a position today.